
The global Dextromethorphan Hydrobromide API market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Dextromethorphan Hydrobromide API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Dextromethorphan Hydrobromide API market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Dextromethorphan Hydrobromide API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Dextromethorphan Hydrobromide API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Dextromethorphan Hydrobromide API market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Dextromethorphan Hydrobromide API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Dextromethorphan Hydrobromide API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Supriya Lifescience, Malladi Drugs & Pharmaceuticals, Rochem International, Tenatra Chemie, Zeon Health Industries, Royal DSM, Aurobindo Pharma, Wanbury Limited, Solara Active Pharma Sciences, Divis Laboratories Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Dextromethorphan Hydrobromide API market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Purity < 98%
Purity > 98%
Market segment by Application
Tablet
Injection
Major players covered
Supriya Lifescience
Malladi Drugs & Pharmaceuticals
Rochem International
Tenatra Chemie
Zeon Health Industries
Royal DSM
Aurobindo Pharma
Wanbury Limited
Solara Active Pharma Sciences
Divis Laboratories Ltd.
Wockhardt
Zhejiang Apeloa Kangyu Pharmaceuticals
Hy-Gro Chemicals Pharmtek
Srini Pharmaceuticals
Exemed Pharmaceuticals
Standard Chem. & Pharm
Lonza Inc
Osmopharm
Kreative Organics
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Dextromethorphan Hydrobromide API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Dextromethorphan Hydrobromide API, with price, sales quantity, revenue, and global market share of Dextromethorphan Hydrobromide API from 2020 to 2025.
Chapter 3, the Dextromethorphan Hydrobromide API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dextromethorphan Hydrobromide API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Dextromethorphan Hydrobromide API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Dextromethorphan Hydrobromide API.
Chapter 14 and 15, to describe Dextromethorphan Hydrobromide API sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Dextromethorphan Hydrobromide API Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Purity < 98%
1.3.3 Purity > 98%
1.4 Market Analysis by Application
1.4.1 Overview: Global Dextromethorphan Hydrobromide API Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Tablet
1.4.3 Injection
1.5 Global Dextromethorphan Hydrobromide API Market Size & Forecast
1.5.1 Global Dextromethorphan Hydrobromide API Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Dextromethorphan Hydrobromide API Sales Quantity (2020-2031)
1.5.3 Global Dextromethorphan Hydrobromide API Average Price (2020-2031)
2 Manufacturers Profiles
2.1 Supriya Lifescience
2.1.1 Supriya Lifescience Details
2.1.2 Supriya Lifescience Major Business
2.1.3 Supriya Lifescience Dextromethorphan Hydrobromide API Product and Services
2.1.4 Supriya Lifescience Dextromethorphan Hydrobromide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Supriya Lifescience Recent Developments/Updates
2.2 Malladi Drugs & Pharmaceuticals
2.2.1 Malladi Drugs & Pharmaceuticals Details
2.2.2 Malladi Drugs & Pharmaceuticals Major Business
2.2.3 Malladi Drugs & Pharmaceuticals Dextromethorphan Hydrobromide API Product and Services
2.2.4 Malladi Drugs & Pharmaceuticals Dextromethorphan Hydrobromide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Malladi Drugs & Pharmaceuticals Recent Developments/Updates
2.3 Rochem International
2.3.1 Rochem International Details
2.3.2 Rochem International Major Business
2.3.3 Rochem International Dextromethorphan Hydrobromide API Product and Services
2.3.4 Rochem International Dextromethorphan Hydrobromide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Rochem International Recent Developments/Updates
2.4 Tenatra Chemie
2.4.1 Tenatra Chemie Details
2.4.2 Tenatra Chemie Major Business
2.4.3 Tenatra Chemie Dextromethorphan Hydrobromide API Product and Services
2.4.4 Tenatra Chemie Dextromethorphan Hydrobromide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Tenatra Chemie Recent Developments/Updates
2.5 Zeon Health Industries
2.5.1 Zeon Health Industries Details
2.5.2 Zeon Health Industries Major Business
2.5.3 Zeon Health Industries Dextromethorphan Hydrobromide API Product and Services
2.5.4 Zeon Health Industries Dextromethorphan Hydrobromide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Zeon Health Industries Recent Developments/Updates
2.6 Royal DSM
2.6.1 Royal DSM Details
2.6.2 Royal DSM Major Business
2.6.3 Royal DSM Dextromethorphan Hydrobromide API Product and Services
2.6.4 Royal DSM Dextromethorphan Hydrobromide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Royal DSM Recent Developments/Updates
2.7 Aurobindo Pharma
2.7.1 Aurobindo Pharma Details
2.7.2 Aurobindo Pharma Major Business
2.7.3 Aurobindo Pharma Dextromethorphan Hydrobromide API Product and Services
2.7.4 Aurobindo Pharma Dextromethorphan Hydrobromide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Aurobindo Pharma Recent Developments/Updates
2.8 Wanbury Limited
2.8.1 Wanbury Limited Details
2.8.2 Wanbury Limited Major Business
2.8.3 Wanbury Limited Dextromethorphan Hydrobromide API Product and Services
2.8.4 Wanbury Limited Dextromethorphan Hydrobromide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Wanbury Limited Recent Developments/Updates
2.9 Solara Active Pharma Sciences
2.9.1 Solara Active Pharma Sciences Details
2.9.2 Solara Active Pharma Sciences Major Business
2.9.3 Solara Active Pharma Sciences Dextromethorphan Hydrobromide API Product and Services
2.9.4 Solara Active Pharma Sciences Dextromethorphan Hydrobromide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Solara Active Pharma Sciences Recent Developments/Updates
2.10 Divis Laboratories Ltd.
2.10.1 Divis Laboratories Ltd. Details
2.10.2 Divis Laboratories Ltd. Major Business
2.10.3 Divis Laboratories Ltd. Dextromethorphan Hydrobromide API Product and Services
2.10.4 Divis Laboratories Ltd. Dextromethorphan Hydrobromide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Divis Laboratories Ltd. Recent Developments/Updates
2.11 Wockhardt
2.11.1 Wockhardt Details
2.11.2 Wockhardt Major Business
2.11.3 Wockhardt Dextromethorphan Hydrobromide API Product and Services
2.11.4 Wockhardt Dextromethorphan Hydrobromide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Wockhardt Recent Developments/Updates
2.12 Zhejiang Apeloa Kangyu Pharmaceuticals
2.12.1 Zhejiang Apeloa Kangyu Pharmaceuticals Details
2.12.2 Zhejiang Apeloa Kangyu Pharmaceuticals Major Business
2.12.3 Zhejiang Apeloa Kangyu Pharmaceuticals Dextromethorphan Hydrobromide API Product and Services
2.12.4 Zhejiang Apeloa Kangyu Pharmaceuticals Dextromethorphan Hydrobromide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Zhejiang Apeloa Kangyu Pharmaceuticals Recent Developments/Updates
2.13 Hy-Gro Chemicals Pharmtek
2.13.1 Hy-Gro Chemicals Pharmtek Details
2.13.2 Hy-Gro Chemicals Pharmtek Major Business
2.13.3 Hy-Gro Chemicals Pharmtek Dextromethorphan Hydrobromide API Product and Services
2.13.4 Hy-Gro Chemicals Pharmtek Dextromethorphan Hydrobromide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Hy-Gro Chemicals Pharmtek Recent Developments/Updates
2.14 Srini Pharmaceuticals
2.14.1 Srini Pharmaceuticals Details
2.14.2 Srini Pharmaceuticals Major Business
2.14.3 Srini Pharmaceuticals Dextromethorphan Hydrobromide API Product and Services
2.14.4 Srini Pharmaceuticals Dextromethorphan Hydrobromide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Srini Pharmaceuticals Recent Developments/Updates
2.15 Exemed Pharmaceuticals
2.15.1 Exemed Pharmaceuticals Details
2.15.2 Exemed Pharmaceuticals Major Business
2.15.3 Exemed Pharmaceuticals Dextromethorphan Hydrobromide API Product and Services
2.15.4 Exemed Pharmaceuticals Dextromethorphan Hydrobromide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Exemed Pharmaceuticals Recent Developments/Updates
2.16 Standard Chem. & Pharm
2.16.1 Standard Chem. & Pharm Details
2.16.2 Standard Chem. & Pharm Major Business
2.16.3 Standard Chem. & Pharm Dextromethorphan Hydrobromide API Product and Services
2.16.4 Standard Chem. & Pharm Dextromethorphan Hydrobromide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 Standard Chem. & Pharm Recent Developments/Updates
2.17 Lonza Inc
2.17.1 Lonza Inc Details
2.17.2 Lonza Inc Major Business
2.17.3 Lonza Inc Dextromethorphan Hydrobromide API Product and Services
2.17.4 Lonza Inc Dextromethorphan Hydrobromide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.17.5 Lonza Inc Recent Developments/Updates
2.18 Osmopharm
2.18.1 Osmopharm Details
2.18.2 Osmopharm Major Business
2.18.3 Osmopharm Dextromethorphan Hydrobromide API Product and Services
2.18.4 Osmopharm Dextromethorphan Hydrobromide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.18.5 Osmopharm Recent Developments/Updates
2.19 Kreative Organics
2.19.1 Kreative Organics Details
2.19.2 Kreative Organics Major Business
2.19.3 Kreative Organics Dextromethorphan Hydrobromide API Product and Services
2.19.4 Kreative Organics Dextromethorphan Hydrobromide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.19.5 Kreative Organics Recent Developments/Updates
3 Competitive Environment: Dextromethorphan Hydrobromide API by Manufacturer
3.1 Global Dextromethorphan Hydrobromide API Sales Quantity by Manufacturer (2020-2025)
3.2 Global Dextromethorphan Hydrobromide API Revenue by Manufacturer (2020-2025)
3.3 Global Dextromethorphan Hydrobromide API Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Dextromethorphan Hydrobromide API by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Dextromethorphan Hydrobromide API Manufacturer Market Share in 2024
3.4.3 Top 6 Dextromethorphan Hydrobromide API Manufacturer Market Share in 2024
3.5 Dextromethorphan Hydrobromide API Market: Overall Company Footprint Analysis
3.5.1 Dextromethorphan Hydrobromide API Market: Region Footprint
3.5.2 Dextromethorphan Hydrobromide API Market: Company Product Type Footprint
3.5.3 Dextromethorphan Hydrobromide API Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Dextromethorphan Hydrobromide API Market Size by Region
4.1.1 Global Dextromethorphan Hydrobromide API Sales Quantity by Region (2020-2031)
4.1.2 Global Dextromethorphan Hydrobromide API Consumption Value by Region (2020-2031)
4.1.3 Global Dextromethorphan Hydrobromide API Average Price by Region (2020-2031)
4.2 North America Dextromethorphan Hydrobromide API Consumption Value (2020-2031)
4.3 Europe Dextromethorphan Hydrobromide API Consumption Value (2020-2031)
4.4 Asia-Pacific Dextromethorphan Hydrobromide API Consumption Value (2020-2031)
4.5 South America Dextromethorphan Hydrobromide API Consumption Value (2020-2031)
4.6 Middle East & Africa Dextromethorphan Hydrobromide API Consumption Value (2020-2031)
5 Market Segment by Type
5.1 Global Dextromethorphan Hydrobromide API Sales Quantity by Type (2020-2031)
5.2 Global Dextromethorphan Hydrobromide API Consumption Value by Type (2020-2031)
5.3 Global Dextromethorphan Hydrobromide API Average Price by Type (2020-2031)
6 Market Segment by Application
6.1 Global Dextromethorphan Hydrobromide API Sales Quantity by Application (2020-2031)
6.2 Global Dextromethorphan Hydrobromide API Consumption Value by Application (2020-2031)
6.3 Global Dextromethorphan Hydrobromide API Average Price by Application (2020-2031)
7 North America
7.1 North America Dextromethorphan Hydrobromide API Sales Quantity by Type (2020-2031)
7.2 North America Dextromethorphan Hydrobromide API Sales Quantity by Application (2020-2031)
7.3 North America Dextromethorphan Hydrobromide API Market Size by Country
7.3.1 North America Dextromethorphan Hydrobromide API Sales Quantity by Country (2020-2031)
7.3.2 North America Dextromethorphan Hydrobromide API Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 Europe
8.1 Europe Dextromethorphan Hydrobromide API Sales Quantity by Type (2020-2031)
8.2 Europe Dextromethorphan Hydrobromide API Sales Quantity by Application (2020-2031)
8.3 Europe Dextromethorphan Hydrobromide API Market Size by Country
8.3.1 Europe Dextromethorphan Hydrobromide API Sales Quantity by Country (2020-2031)
8.3.2 Europe Dextromethorphan Hydrobromide API Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Dextromethorphan Hydrobromide API Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Dextromethorphan Hydrobromide API Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Dextromethorphan Hydrobromide API Market Size by Region
9.3.1 Asia-Pacific Dextromethorphan Hydrobromide API Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Dextromethorphan Hydrobromide API Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 South America
10.1 South America Dextromethorphan Hydrobromide API Sales Quantity by Type (2020-2031)
10.2 South America Dextromethorphan Hydrobromide API Sales Quantity by Application (2020-2031)
10.3 South America Dextromethorphan Hydrobromide API Market Size by Country
10.3.1 South America Dextromethorphan Hydrobromide API Sales Quantity by Country (2020-2031)
10.3.2 South America Dextromethorphan Hydrobromide API Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Dextromethorphan Hydrobromide API Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Dextromethorphan Hydrobromide API Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Dextromethorphan Hydrobromide API Market Size by Country
11.3.1 Middle East & Africa Dextromethorphan Hydrobromide API Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Dextromethorphan Hydrobromide API Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 Market Dynamics
12.1 Dextromethorphan Hydrobromide API Market Drivers
12.2 Dextromethorphan Hydrobromide API Market Restraints
12.3 Dextromethorphan Hydrobromide API Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Dextromethorphan Hydrobromide API and Key Manufacturers
13.2 Manufacturing Costs Percentage of Dextromethorphan Hydrobromide API
13.3 Dextromethorphan Hydrobromide API Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Dextromethorphan Hydrobromide API Typical Distributors
14.3 Dextromethorphan Hydrobromide API Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Supriya Lifescience
Malladi Drugs & Pharmaceuticals
Rochem International
Tenatra Chemie
Zeon Health Industries
Royal DSM
Aurobindo Pharma
Wanbury Limited
Solara Active Pharma Sciences
Divis Laboratories Ltd.
Wockhardt
Zhejiang Apeloa Kangyu Pharmaceuticals
Hy-Gro Chemicals Pharmtek
Srini Pharmaceuticals
Exemed Pharmaceuticals
Standard Chem. & Pharm
Lonza Inc
Osmopharm
Kreative Organics
Ìý
Ìý
*If Applicable.
